David Young
CIK 1378166 · Pres. Research & Development · last filed 2026-06-01
David Young is a Pres. Research & Development who has filed 63 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider bought $4.6K of PCSA on Jun 1, 2026. Across all open-market trades the lifetime net is −$14.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $38.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$38.1K
3
63
-$14.49M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCSA | Pres. Research & Development | 17,563 | $2.17 | $38.1K | $373.0K | 37 | 2026-06-01 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Chief Scientific Officer | 122,366 | — | — | -$14.87M | 21 | 2014-03-18 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | — | — | — | $0 | 4 | 2008-01-03 |
Recent Filings
63 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-01 | PCSA | Buy (P) | +1,786 | $4.6K | EDGAR |
| 2026-05-19 | PCSA | Buy (P) | +1,545 | $4.6K | EDGAR |
| 2026-05-01 | PCSA | Buy (P) | +1,706 | $4.6K | EDGAR |
| 2026-04-17 | PCSA | Buy (P) | +1,545 | $4.6K | EDGAR |
| 2026-04-01 | PCSA | Buy (P) | +1,810 | $4.6K | EDGAR |
| 2026-02-04 | PCSA | Exer (M) | +49 | $0 | EDGAR |
| 2025-10-03 | PCSA | Grant (A) | — | $0 | EDGAR |
| 2025-09-18 | PCSA | — | — | $0 | EDGAR |
| 2025-07-28 | PCSA | Grant (A) | — | $0 | EDGAR |
| 2025-04-11 | PCSA | Mixed | +11,927 | -$2.2K | EDGAR |